Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,599 | 119 | 80.2% |
| Travel and Lodging | $641.84 | 3 | 19.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,670 | 26 | $0 (2023) |
| ABBVIE INC. | $625.91 | 53 | $0 (2024) |
| Medtronic USA, Inc. | $394.83 | 10 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $195.55 | 12 | $0 (2024) |
| Allergan, Inc. | $118.31 | 8 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $100.58 | 6 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $73.52 | 4 | $0 (2024) |
| DJO, LLC | $23.83 | 1 | $0 (2017) |
| Lilly USA, LLC | $20.21 | 1 | $0 (2024) |
| Fidia Pharma USA Inc. | $19.04 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $436.19 | 34 | ABBVIE INC. ($234.12) |
| 2023 | $1,871 | 52 | Medtronic, Inc. ($1,498) |
| 2022 | $97.00 | 6 | ABBVIE INC. ($32.41) |
| 2021 | $275.84 | 10 | Medtronic, Inc. ($171.48) |
| 2020 | $53.84 | 4 | Ipsen Biopharmaceuticals, Inc ($28.11) |
| 2019 | $265.26 | 6 | Medtronic USA, Inc. ($237.33) |
| 2018 | $117.10 | 4 | Medtronic USA, Inc. ($85.54) |
| 2017 | $125.55 | 6 | Medtronic USA, Inc. ($60.91) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/09/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: Opioid Analgesic | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Opioid Analgesic | ||||||
| 08/09/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/01/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.55 | General |
| Category: Opioid Analgesic | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 98 | $20,228 | $8,424 |
| 2022 | 3 | 64 | 124 | $24,818 | $9,975 |
| 2021 | 2 | 43 | 95 | $16,507 | $7,280 |
| 2020 | 1 | 14 | 38 | $8,062 | $2,806 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 49 | $10,606 | $4,384 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 18 | $5,140 | $2,228 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 31 | $4,483 | $1,813 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 50 | $10,608 | $4,152 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 49 | $7,085 | $3,004 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 25 | $7,125 | $2,819 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 41 | $8,699 | $3,647 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 54 | $7,808 | $3,632 | 46.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 38 | $8,062 | $2,806 | 34.8% |
About Dr. Adam Rush, MD
Dr. Adam Rush, MD is a Physical Medicine & Rehabilitation healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528095643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Rush, MD has received a total of $3,241 in payments from pharmaceutical and medical device companies, with $436.19 received in 2024. These payments were reported across 122 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,599).
As a Medicare-enrolled provider, Rush has provided services to 178 Medicare beneficiaries, totaling 355 services with total Medicare billing of $28,485. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation, Physical Medicine & Rehabilitation
- Location Grand Rapids, MI
- Active Since 06/26/2006
- Last Updated 08/02/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528095643
Products in Payments
- SYNCHROMEDII (Device) $1,498
- SYNCHROMED (Device) $400.35
- UBRELVY (Drug) $284.77
- BOTOX (Biological) $215.30
- QULIPTA (Drug) $209.07
- Qelbree (Drug) $108.34
- QELBREE (Drug) $87.21
- ASCENDA (Device) $84.32
- Belbuca (Drug) $73.52
- SPECIFY (Device) $67.56
- DYSPORT (Drug) $63.29
- CMF OL1000 (Device) $23.83
- Dysport 300 U-1 (Drug) $23.41
- EMGALITY (Drug) $20.21
- HYMOVIS (Device) $19.04
- BOTOX THERAPEUTIC (Biological) $17.68
- BOTOX - NEURO REHAB (Drug) $17.40
- LIORESAL (Device) $14.08
- Dysport (Drug) $13.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Grand Rapids
Emily Gladstone, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $10,120
Dr. Stuart Yablon, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $6,859
Dr. Sampson Ho, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,434
Adam Hull, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $4,352
Dr. Jonathan Vandenberg, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,860
Dr. Aashish Deshpande, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,499